Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

EndoPod

COVID-19 & Cushing's - Simplified

21 Jun 2020

Description

Welcome back to EndoPod! This week, we're going to be looking at how patients with Cushing's syndrome are affected by lockdown and the coronavirus. We even have a personal story in this episode - not to be missed. This is a simplified version for our listeners who do not have a medical background. Sit back and enjoy! Disclaimer: Aberdeen University Endocrinology Society are a student lead organisation. All information provided in this podcast are intended for educational purposes. This podcast is not intended to replace the advice of a qualified health professional. The students involved in the making of this episode are in the 3rd year of MBChB studies (Hepsi Xavier, Arabella Baptie) References used: https://pituitary.org.uk/media/604535/Cushings-management-during-COVID-19-_Lay-Summary-FINAL.pdf https://cushingsdiseasenews.com/2019/10/03/cushings-disease-can-lead-opportunistic-infections-like-tuberculous-meningitis-case-report/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3892578/ https://www.endocrinology.org/clinical-practice/covid-19-resources-for-managing-endocrine-conditions/ https://europepmc.org/article/pmc/pmc7282791 https://www.sciencedirect.com/science/article/pii/S1871402120301697 https://eje.bioscientifica.com/view/journals/eje/183/1/EJE-20-0352.xml https://cushingsdiseasenews.com/2020/04/10/aace-issues-recommendations-cushings-patients-covid-19/ https://www.uptodate.com/contents/coronavirus-disease-2019-covid-19-hypercoagulability#H598527523 https://academic.oup.com/jcem/article/94/8/2743/2596482 https://www.pituitary.org.uk/information/pituitary-conditions/cushings-disease/

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.